Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Co-crystallization induced spontaneous deracemization: A general thermodynamic approach to deracemization.

Guillot M, de Meester J, Huynen S, Collard L, Robeyns K, Riant O, Leyssens T.

Angew Chem Int Ed Engl. 2020 Mar 20. doi: 10.1002/anie.202002464. [Epub ahead of print]

PMID:
32196879
2.

The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2016: a summary.

Kramer A, Pippias M, Noordzij M, Stel VS, Andrusev AM, Aparicio-Madre MI, Arribas Monzón FE, Åsberg A, Barbullushi M, Beltrán P, Bonthuis M, Caskey FJ, Castro de la Nuez P, Cernevskis H, De Meester J, Finne P, Golan E, Heaf JG, Hemmelder MH, Ioannou K, Kantaria N, Komissarov K, Korejwo G, Kramar R, Lassalle M, Lopot F, Macário F, Mackinnon B, Pálsson R, Pechter Ü, Piñera VC, Santiuste de Pablos C, Segarra-Medrano A, Seyahi N, Slon Roblero MF, Stojceva-Taneva O, Vazelov E, Winzeler R, Ziginskiene E, Massy Z, Jager KJ.

Clin Kidney J. 2019 Feb 26;12(5):702-720. doi: 10.1093/ckj/sfz011. eCollection 2019 Oct.

3.

International comparison of trends in patients commencing renal replacement therapy by primary renal disease.

Stel VS, Awadhpersad R, Pippias M, Ferrer-Alamar M, Finne P, Fraser SD, Heaf JG, Hemmelder MH, Martínez-Castelao A, de Meester J, Palsson R, Prischl FC, Segelmark M, Traynor JP, Santamaria R, Reisaeter AV, Massy ZA, Jager KJ.

Nephrology (Carlton). 2019 Oct;24(10):1064-1076. doi: 10.1111/nep.13531. Epub 2019 Apr 29.

PMID:
30456883
4.

Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry.

Hruskova Z, Pippias M, Stel VS, Abad-Díez JM, Benítez Sánchez M, Caskey FJ, Collart F, De Meester J, Finne P, Heaf JG, Magaz A, Palsson R, Reisæter AV, Salama AD, Segelmark M, Traynor JP, Massy ZA, Jager KJ, Tesar V.

Am J Kidney Dis. 2019 Feb;73(2):184-193. doi: 10.1053/j.ajkd.2018.05.016. Epub 2018 Aug 16.

PMID:
30122544
5.

Mortality due to bleeding, myocardial infarction and stroke in dialysis patients.

Ocak G, Noordzij M, Rookmaaker MB, Cases A, Couchoud C, Heaf JG, Jarraya F, De Meester J, Groothoff JW, Waldum-Grevbo BE, Palsson R, Resic H, Remón C, Finne P, Stendahl M, Verhaar MC, Massy ZA, Dekker FW, Jager KJ.

J Thromb Haemost. 2018 Oct;16(10):1953-1963. doi: 10.1111/jth.14254. Epub 2018 Aug 22.

PMID:
30063819
6.

Factors associating with differences in the incidence of renal replacement therapy among elderly: data from the ERA-EDTA Registry.

Helve J, Kramer A, Abad-Diez JM, Couchoud C, de Arriba G, de Meester J, Evans M, Glaudet F, Grönhagen-Riska C, Heaf JG, Lezaic V, Nordio M, Palsson R, Pechter Ü, Resic H, Santamaria R, Santiuste de Pablos C, Massy ZA, Zurriaga Ó, Jager KJ, Finne P.

Nephrol Dial Transplant. 2018 Aug 1;33(8):1428-1435. doi: 10.1093/ndt/gfy056.

PMID:
29684185
7.

Access to kidney transplantation in European adults aged 75-84 years and related outcomes: an analysis of the European Renal Association-European Dialysis and Transplant Association Registry.

Pippias M, Stel VS, Kramer A, Abad Diez JM, Aresté-Fosalba N, Ayav C, Buturovic J, Caskey FJ, Collart F, Couchoud C, De Meester J, Heaf JG, Helanterä I, Hemmelder MH, Kostopoulou M, Noordzij M, Pascual J, Palsson R, Reisaeter AV, Traynor JP, Massy Z, Jager KJ.

Transpl Int. 2018 May;31(5):540-553. doi: 10.1111/tri.13125. Epub 2018 Mar 2.

8.

Changes in co-morbidity pattern in patients starting renal replacement therapy in Europe-data from the ERA-EDTA Registry.

Ceretta ML, Noordzij M, Luxardo R, De Meester J, Abad Diez JM, Finne P, Heaf JG, Couchoud C, Kramar R, Collart F, Cases A, Palsson R, Reisæter AV, Rydell H, Massy ZA, Jager KJ, Kramer A.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1794-1804. doi: 10.1093/ndt/gfx355.

PMID:
29361126
9.

Performance of an easy-to-use prediction model for renal patient survival: an external validation study using data from the ERA-EDTA Registry.

Hemke AC, Heemskerk MBA, van Diepen M, Kramer A, de Meester J, Heaf JG, Abad Diez JM, Torres Guinea M, Finne P, Brunet P, Vikse BE, Caskey FJ, Traynor JP, Massy ZA, Couchoud C, Groothoff JW, Nordio M, Jager KJ, Dekker FW, Hoitsma AJ.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1786-1793. doi: 10.1093/ndt/gfx348.

PMID:
29346645
10.

Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses.

Ghinnagow R, De Meester J, Cruz LJ, Aspord C, Corgnac S, Macho-Fernandez E, Soulard D, Fontaine J, Chaperot L, Charles J, Soncin F, Mami-Chouaib F, Plumas J, Faveeuw C, Trottein F.

Oncoimmunology. 2017 Aug 18;6(9):e1339855. doi: 10.1080/2162402X.2017.1339855. eCollection 2017.

11.

Lifetime risk of renal replacement therapy in Europe: a population-based study using data from the ERA-EDTA Registry.

van den Brand JAJG, Pippias M, Stel VS, Caskey FJ, Collart F, Finne P, Heaf J, Jais JP, Kramar R, Massy ZA, De Meester J, Traynor JP, Reisæter AV, Wetzels JFM, Jager KJ.

Nephrol Dial Transplant. 2017 Feb 1;32(2):348-355. doi: 10.1093/ndt/gfw392.

PMID:
28031344
12.

The expanded criteria donor for kidney transplant: not a nearly new car.

De Meester J.

Transpl Int. 2017 Jan;30(1):11-13. doi: 10.1111/tri.12880. No abstract available.

13.

Measuring senescence rates of patients with end-stage renal disease while accounting for population heterogeneity: an analysis of data from the ERA-EDTA Registry.

Koopman JJ, Kramer A, van Heemst D, Åsberg A, Beuscart JB, Buturović-Ponikvar J, Collart F, Couchoud CG, Finne P, Heaf JG, Massy ZA, De Meester JM, Palsson R, Steenkamp R, Traynor JP, Jager KJ, Putter H.

Ann Epidemiol. 2016 Nov;26(11):773-779. doi: 10.1016/j.annepidem.2016.08.010. Epub 2016 Aug 31.

PMID:
27665405
14.

Impact of food processing and detoxification treatments on mycotoxin contamination.

Karlovsky P, Suman M, Berthiller F, De Meester J, Eisenbrand G, Perrin I, Oswald IP, Speijers G, Chiodini A, Recker T, Dussort P.

Mycotoxin Res. 2016 Nov;32(4):179-205. Epub 2016 Aug 23. Review.

15.

Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus.

Kramer A, Pippias M, Stel VS, Bonthuis M, Abad Diez JM, Afentakis N, Alonso de la Torre R, Ambuhl P, Bikbov B, Bouzas Caamaño E, Bubic I, Buturovic-Ponikvar J, Caskey FJ, Castro de la Nuez P, Cernevskis H, Collart F, Comas Farnés J, Garcia Bazaga Mde L, De Meester J, Ferrer Alamar M, Finne P, Garneata L, Golan E, G Heaf J, Hemmelder M, Ioannou K, Kantaria N, Kolesnyk M, Kramar R, Lassalle M, Lezaic V, Lopot F, Macário F, Magaz A, Martín-Escobar E, Metcalfe W, Ots-Rosenberg M, Palsson R, Piñera Celestino C, Resić H, Rutkowski B, Santiuste de Pablos C, Spustová V, Stendahl M, Strakosha A, Süleymanlar G, Torres Guinea M, Varberg Reisæter A, Vazelov E, Ziginskiene E, Massy ZA, Wanner C, Jager KJ, Noordzij M.

Clin Kidney J. 2016 Jun;9(3):457-69. doi: 10.1093/ckj/sfv151. Epub 2016 Jan 31.

16.

External Validation of a risk stratification model to assist shared decision making for patients starting renal replacement therapy.

Peeters P, Van Biesen W, Veys N, Lemahieu W, De Moor B, De Meester J.

BMC Nephrol. 2016 Apr 7;17:41. doi: 10.1186/s12882-016-0253-3.

17.

Long-term Kidney Transplant Outcomes in Primary Glomerulonephritis: Analysis From the ERA-EDTA Registry.

Pippias M, Stel VS, Aresté-Fosalba N, Couchoud C, Fernandez-Fresnedo G, Finne P, Heaf JG, Hoitsma A, De Meester J, Pálsson R, Ravani P, Segelmark M, Traynor JP, Reisæter AV, Caskey FJ, Jager KJ.

Transplantation. 2016 Sep;100(9):1955-62. doi: 10.1097/TP.0000000000000962.

PMID:
26588008
18.

The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry.

Pippias M, Jager KJ, Kramer A, Leivestad T, Sánchez MB, Caskey FJ, Collart F, Couchoud C, Dekker FW, Finne P, Fouque D, Heaf JG, Hemmelder MH, Kramar R, De Meester J, Noordzij M, Palsson R, Pascual J, Zurriaga O, Wanner C, Stel VS.

Nephrol Dial Transplant. 2016 May;31(5):831-41. doi: 10.1093/ndt/gfv327. Epub 2015 Sep 11.

PMID:
26361801
19.

Renal replacement therapy in Europe: a summary of the 2012 ERA-EDTA Registry Annual Report.

Pippias M, Stel VS, Abad Diez JM, Afentakis N, Herrero-Calvo JA, Arias M, Tomilina N, Bouzas Caamaño E, Buturovic-Ponikvar J, Čala S, Caskey FJ, Castro de la Nuez P, Cernevskis H, Collart F, Alonso de la Torre R, García Bazaga Mde L, De Meester J, Díaz JM, Djukanovic L, Ferrer Alamar M, Finne P, Garneata L, Golan E, González Fernández R, Gutiérrez Avila G, Heaf J, Hoitsma A, Kantaria N, Kolesnyk M, Kramar R, Kramer A, Lassalle M, Leivestad T, Lopot F, Macário F, Magaz A, Martín-Escobar E, Metcalfe W, Noordzij M, Palsson R, Pechter Ü, Prütz KG, Ratkovic M, Resić H, Rutkowski B, Santiuste de Pablos C, Spustová V, Süleymanlar G, Van Stralen K, Thereska N, Wanner C, Jager KJ.

Clin Kidney J. 2015 Jun;8(3):248-61. doi: 10.1093/ckj/sfv014. Epub 2015 Mar 23.

20.

Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.

Hruskova Z, Stel VS, Jayne D, Aasarød K, De Meester J, Ekstrand A, Eller K, Heaf JG, Hoitsma A, Martos Jimenéz C, Ravani P, Wanner C, Tesar V, Jager KJ.

Am J Kidney Dis. 2015 Oct;66(4):613-20. doi: 10.1053/j.ajkd.2015.03.025. Epub 2015 May 12.

PMID:
25975963
21.

Calculating the Rate of Senescence From Mortality Data: An Analysis of Data From the ERA-EDTA Registry.

Koopman JJ, Rozing MP, Kramer A, Abad JM, Finne P, Heaf JG, Hoitsma AJ, De Meester JM, Palsson R, Postorino M, Ravani P, Wanner C, Jager KJ, van Bodegom D, Westendorp RG.

J Gerontol A Biol Sci Med Sci. 2016 Apr;71(4):468-74. doi: 10.1093/gerona/glv042. Epub 2015 Apr 16.

PMID:
25887122
22.

Renal replacement therapy in Europe: a summary of the 2011 ERA-EDTA Registry Annual Report.

Noordzij M, Kramer A, Abad Diez JM, Alonso de la Torre R, Arcos Fuster E, Bikbov BT, Bonthuis M, Bouzas Caamaño E, Čala S, Caskey FJ, Castro de la Nuez P, Cernevskis H, Collart F, Díaz Tejeiro R, Djukanovic L, Ferrer-Alamar M, Finne P, García Bazaga Mde L, Garneata L, Golan E, Gonzalez Fernández R, Heaf JG, Hoitsma A, Ioannidis GA, Kolesnyk M, Kramar R, Lasalle M, Leivestad T, Lopot F, van de Luijtgaarden MW, Macário F, Magaz Á, Martín Escobar E, de Meester J, Metcalfe W, Ots-Rosenberg M, Palsson R, Piñera C, Pippias M, Prütz KG, Ratkovic M, Resić H, Rodríguez Hernández A, Rutkowski B, Spustová V, Stel VS, Stojceva-Taneva O, Süleymanlar G, Wanner C, Jager KJ.

Clin Kidney J. 2014 Apr;7(2):227-38. doi: 10.1093/ckj/sfu007. Epub 2014 Mar 2.

23.

Mortality from infections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA registry.

Vogelzang JL, van Stralen KJ, Noordzij M, Diez JA, Carrero JJ, Couchoud C, Dekker FW, Finne P, Fouque D, Heaf JG, Hoitsma A, Leivestad T, de Meester J, Metcalfe W, Palsson R, Postorino M, Ravani P, Vanholder R, Wallner M, Wanner C, Groothoff JW, Jager KJ.

Nephrol Dial Transplant. 2015 Jun;30(6):1028-37. doi: 10.1093/ndt/gfv007. Epub 2015 Jan 29.

PMID:
25637641
24.

Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry.

Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Abad JM, Aresté N, de la Torre RA, Caskey F, Couchoud C, Finne P, Heaf J, Hoitsma A, de Meester J, Pascual J, Postorino M, Ravani P, Zurriaga O, Jager KJ, Gansevoort RT; ERA-EDTA Registry; EuroCYST Consortium; WGIKD.

Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv15-25. doi: 10.1093/ndt/gfu017.

25.

Renal replacement therapy in Europe-a summary of the 2010 ERA-EDTA Registry Annual Report.

Kramer A, Stel VS, Abad Diez JM, Alonso de la Torre R, Bouzas Caamaño E, Čala S, Cao Baduell H, Castro de la Nuez P, Cernevskis H, Collart F, Couchoud C, de Meester J, Djukanovic L, Ferrer-Alamar M, Finne P, Fogarty D, de Los Ángeles García Bazaga M, Garneata L, Golan E, Gonzalez Fernández R, Heaf JG, Hoitsma A, Ioannidis GA, Kolesnyk M, Kramar R, Leivestad T, Limido A, Lopot F, Macario F, Magaz Á, Martín-Escobar E, Metcalfe W, Noordzij M, Ots-Rosenberg M, Palsson R, Piñera C, Postorino M, Prutz KG, Ratkovic M, Resic H, Rodríguez Hernández A, Rutkowski B, Serdengeçti K, Yebenes TS, Spustová V, Stojceva-Taneva O, Tomilina NA, van de Luijtgaarden MW, van Stralen KJ, Wanner C, Jager KJ.

Clin Kidney J. 2013 Feb;6(1):105-115.

26.

New primary renal diagnosis codes for the ERA-EDTA.

Venkat-Raman G, Tomson CR, Gao Y, Cornet R, Stengel B, Gronhagen-Riska C, Reid C, Jacquelinet C, Schaeffner E, Boeschoten E, Casino F, Collart F, De Meester J, Zurriaga O, Kramar R, Jager KJ, Simpson K; ERA-EDTA Registry.

Nephrol Dial Transplant. 2012 Dec;27(12):4414-9. doi: 10.1093/ndt/gfs461. Epub 2012 Nov 22.

27.

Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients.

Ocak G, van Stralen KJ, Rosendaal FR, Verduijn M, Ravani P, Palsson R, Leivestad T, Hoitsma AJ, Ferrer-Alamar M, Finne P, De Meester J, Wanner C, Dekker FW, Jager KJ.

J Thromb Haemost. 2012 Dec;10(12):2484-93. doi: 10.1111/j.1538-7836.2012.04921.x.

28.

Cardiovascular and noncardiovascular mortality among men and women starting dialysis.

Carrero JJ, de Jager DJ, Verduijn M, Ravani P, De Meester J, Heaf JG, Finne P, Hoitsma AJ, Pascual J, Jarraya F, Reisaeter AV, Collart F, Dekker FW, Jager KJ.

Clin J Am Soc Nephrol. 2011 Jul;6(7):1722-30. doi: 10.2215/CJN.11331210.

29.

Exploration of the difference in incidence of renal replacement therapy between Flanders and the Netherlands--investigation of explanatory variables.

Visser A, Noordzij M, Gansevoort RT, Van Biesen W, Reijneveld SA, Jager KJ, de Jong PE, Izaks GJ, Dijkstra GJ, De Meester J, Hoitsma AJ, Franssen CF.

Nephrol Dial Transplant. 2012 Feb;27(2):803-9. doi: 10.1093/ndt/gfr297. Epub 2011 Jun 9.

PMID:
21669881
30.

The Wiskott-Aldrich syndrome protein permits assembly of a focused immunological synapse enabling sustained T-cell receptor signaling.

Calvez R, Lafouresse F, De Meester J, Galy A, Valitutti S, Dupré L.

Haematologica. 2011 Oct;96(10):1415-23. doi: 10.3324/haematol.2011.040204. Epub 2011 Jun 9.

31.

Fluctuations of haemoglobinaemia in chronic haemodialysis patients.

De Meester J, Maes B, De Vriese A, De Moor B, Donck J, Helbert M, Bammens B, Jamar S.

Acta Clin Belg. 2011 Mar-Apr;66(2):123-8.

PMID:
21630609
32.

Extended dosing of darbepoetin alfa in peritoneal dialysis patients.

Feriani M, De Meester JM, McMahon LP, Rottembourg JB, Bridges I, Farouk M, Pronai W.

BMC Nephrol. 2011 Mar 24;12:13. doi: 10.1186/1471-2369-12-13.

33.

An observational study of the effectiveness of darbepoetin alpha administered in dialysis patients once every 2 weeks for 12 months.

Rottembourg JB, Bridges I, Pronai W, Feriani M, McMahon LP, De Meester JM, Farouk M, Molemans B.

Clin Nephrol. 2011 Mar;75(3):242-50.

PMID:
21329635
34.

Senescence rates in patients with end-stage renal disease: a critical appraisal of the Gompertz model.

Koopman JJ, Rozing MP, Kramer A, de Jager DJ, Ansell D, De Meester JM, Prütz KG, Finne P, Heaf JG, Palsson R, Kramar R, Jager KJ, Dekker FW, Westendorp RG.

Aging Cell. 2011 Apr;10(2):233-8. doi: 10.1111/j.1474-9726.2010.00659.x. Epub 2010 Dec 29.

35.

Simple assessment of patient's stage of chronic kidney disease using eGFR-MDRD nomograms.

Eloot S, Van Vlem B, De Meester J.

Int Urol Nephrol. 2012 Feb;44(1):207-12. doi: 10.1007/s11255-010-9849-x. Epub 2010 Oct 21.

PMID:
20963489
36.

The Wiskott-Aldrich syndrome protein regulates CTL cytotoxicity and is required for efficient killing of B cell lymphoma targets.

De Meester J, Calvez R, Valitutti S, Dupré L.

J Leukoc Biol. 2010 Nov;88(5):1031-40. doi: 10.1189/jlb.0410197. Epub 2010 Aug 5.

PMID:
20689099
37.

Level of renal function in patients starting dialysis: an ERA-EDTA Registry study.

Stel VS, Tomson C, Ansell D, Casino FG, Collart F, Finne P, Ioannidis GA, De Meester J, Salomone M, Traynor JP, Zurriaga O, Jager KJ.

Nephrol Dial Transplant. 2010 Oct;25(10):3315-25. doi: 10.1093/ndt/gfq209. Epub 2010 Apr 16.

PMID:
20400449
38.

Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study.

Tsakiris DJ, Stel VS, Finne P, Fraser E, Heaf J, de Meester J, Schmaldienst S, Dekker F, Verrina E, Jager KJ.

Nephrol Dial Transplant. 2010 Apr;25(4):1200-6. doi: 10.1093/ndt/gfp679. Epub 2009 Dec 27.

PMID:
20037169
39.

Cardiovascular and noncardiovascular mortality among patients starting dialysis.

de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, Collart F, Finne P, Heaf JG, De Meester J, Wetzels JF, Rosendaal FR, Dekker FW.

JAMA. 2009 Oct 28;302(16):1782-9. doi: 10.1001/jama.2009.1488.

PMID:
19861670
40.

HDF promise for the future.

Lornoy W, De Meester J.

Nephrol Dial Transplant. 2008 Aug;23(8):2705-6; author reply 2706-7. doi: 10.1093/ndt/gfn283. Epub 2008 May 21. No abstract available.

41.

Severe diarrhea in renal transplant patients: results of the DIDACT study.

Maes B, Hadaya K, de Moor B, Cambier P, Peeters P, de Meester J, Donck J, Sennesael J, Squifflet JP.

Am J Transplant. 2006 Jun;6(6):1466-72. Erratum in: Am J Transplant. 2007 Mar;7(3):729. Am J Transplant. 2007 May;7(5):1317.

42.

Impact of convective flow on phosphorus removal in maintenance hemodialysis patients.

Lornoy W, De Meester J, Becaus I, Billiouw JM, Van Malderen PA, Van Pottelberge M.

J Ren Nutr. 2006 Jan;16(1):47-53.

PMID:
16414441
43.

Preservation of renal function after heart transplantation: initial single-center experience with sirolimus.

De Meester JM, Van Vlem B, Walravens M, Vanderheyden M, Verstreken S, Goethals M, Kerre N, Wellens F.

Transplant Proc. 2005 May;37(4):1835-8.

PMID:
15919481
44.

A prognostic model for predicting waiting-list mortality for a total national cohort of adult heart-transplant candidates.

Smits JM, Deng MC, Hummel M, De Meester J, Schoendube F, Scheld HH, Persijn GG, Laufer G, Van Houwelingen HC; Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group.

Transplantation. 2003 Oct 27;76(8):1185-9.

PMID:
14578751
45.

Mortality rates after heart transplantation: how to compare center-specific outcome data?

Smits JM, De Meester J, Deng MC, Scheld HH, Hummel M, Schoendube F, Haverich A, Vanhaecke J, van Houwelingen HC; COCPIT Study Group; Eurotransplant heart transplant programs.

Transplantation. 2003 Jan 15;75(1):90-6.

PMID:
12544878
46.

Which ABO-matching rule should be the decisive factor in the choice between a highly urgent and an elective patient?

de Meester J, Bogers M, de Winter H, Smits J, Meester L, Dekking M, Lootsma F, Persijn G, Mühlbacher F.

Transpl Int. 2002 Sep;15(8):431-5. Epub 2002 Jul 31.

PMID:
12221464
47.
48.

Cardioscopy and robotic assistance for the diagnosis of intraventricular endocarditis.

Arbatli H, Hendrickx B, De Meester J, Vanermen H, Farhat F.

J Heart Valve Dis. 2001 Sep;10(5):686-8.

PMID:
11603610
49.

Iso-risk curves as a tool for clinical decision-making: donor factors and medical urgency in cardiac transplantation.

De Meester JM, Smits JM, Rutgerink E, Persijn GG, Haverich A.

J Heart Lung Transplant. 2001 Oct;20(10):1099-105.

PMID:
11595565
50.

Renal retransplantation of children: is a policy 'first cadaver donor, then live donor' an acceptable option?

De Meester J, Smits JM, Offner G, Persijn GG.

Pediatr Transplant. 2001 Jun;5(3):179-86.

PMID:
11422820

Supplemental Content

Loading ...
Support Center